Events Speakers Talks
 

Speakers

Sort by
Newest
Trending
1-13 of 13
1-13 of 13
Filter
Blair Curless
Clinical Pharmacist at Phoebe Putney Health System
absorption (pharmacology), advertising, analgesic, anti-inflammatory, aphria (company), bioavailability, brand, budtender, cannabidiol, cannabinoid, cannabinoid receptor type 1, cannabinoid receptor type 2, cannabis, cannabis (drug), cannabis edible, class action, coffee, cosmetics, damages, dietary supplement, distribution (marketing), doctor of pharmacy, dose (biochemistry), drug, euphoria, false advertising, federal trade commission, flavor, food, food and drug administration, hemp, interleukin 17, kool-aid, law, lawsuit, ligand (biochemistry), marketplace, medical cannabis, medication, mountain dew, nestea, new drug application, nonsteroidal anti-inflammatory drug, novel food, opioid, pharmaceutical formulation, pharmacology, pharmacy, pharmacy school, pricing, product testing, recycling, regulatory compliance, retail, route of administration, shelf life, social media, soft drink, sublingual administration, tea, tetrahydrocannabinol, tetrahydrocannabivarin, toast (honor), topical medication
Liz Geisleman
Vice President at Rocky Mountain Reagents
advertising, anti-inflammatory, brand, budtender, cannabidiol, cannabinoid, cannabinol, cannabis, cannabis (drug), cannabis indica, chromatography, class action, damages, delta-8-tetrahydrocannabinol, dietary supplement, dose (biochemistry), drug, drug enforcement administration, false advertising, federal trade commission, food, food and drug administration, good manufacturing practice, hemp, instagram, law, lawsuit, license, linkedin, medical cannabis, medication, new drug application, nutraceutical, pharmaceutical industry, pharmacy, product testing, qr code, regulatory compliance, social media, target audience, terpene, tetrahydrocannabinol, youtube
Ronie Schmelz
Counsel at Tucker Ellis, LLP
advertising, anti-inflammatory, brand, budtender, cannabidiol, cannabis (drug), class action, damages, dietary supplement, dose (biochemistry), drug, false advertising, federal trade commission, food, food and drug administration, hemp, law, lawsuit, medical cannabis, medication, new drug application, pharmacy, product testing, regulatory compliance, social media
Jessica Arent
Chief Compliance Officer at Cannabidiol Life
advertising, anti-inflammatory, audience measurement, audit, avatar (computing), barcode, bioavailability, biodegradation, biomass, bioplastic, brand, budtender, candy, cannabidiol, cannabinoid, cannabis, cannabis (drug), carbon dioxide, certificate of analysis, certification, chernobyl disaster, class action, clinical trial, concept, controlled substances act, cosmetics, cotton, credibility, customer experience, damages, dietary supplement, don julio, dose (biochemistry), drug, economic development, emulsion, end user, false advertising, fda warning letter, federal trade commission, food, food and drug administration, generally recognized as safe, good manufacturing practice, graphic design, greenwashing, gummy candy, hemp, hydrophobe, ibuprofen, inbound marketing, instagram, internet, kashrut, landfill, law, lawsuit, linkedin, liquid, massage, medical cannabis, medicare (united states), medication, mind, new drug application, non-disclosure agreement, nonsteroidal anti-inflammatory drug, organic certification, over-the-counter drug, packaging and labeling, paracetamol, personal protective equipment, pesticide, petroleum, pharmaceutical industry, pharmacy, plastic bag, podcast, pricing, product testing, publicist, publishing, radio advertisement, recycling, regulatory compliance, shampoo, social media, social media marketing, social stigma, soil, solution, supply chain, sustainability, symbol, target corporation, target market, tax, testimonial, tetrahydrocannabinol, textile, tylenol (brand), understanding, vlog, washing machine, waste, water
Michael Chang
Medical Director at Nutex Health
arthritis, bioavailability, brand, budtender, cannabidiol, cannabinoid, cannabinoid receptor type 1, cannabinoid receptor type 2, cannabinol, cannabis, cannabis (drug), cannabis edible, cannabis indica, cannabis sativa, carbamazepine, chemistry, consumer protection, cytochrome p450, dietary supplement, dose (biochemistry), dream, drug development, effects of cannabis, emergency department, emulsion, endocannabinoid system, fibromyalgia, food and drug administration, gpr55, health, homeostasis, human, hydroxychloroquine, ibuprofen, medical school, medicine, memory, morphine, omega-3 fatty acid, omega-6 fatty acid, opiate, paracetamol, petroleum, pharmaceutical formulation, pharmaceutical industry, pharmacokinetics, pharmacology, placebo, psilocybin mushroom, randomized controlled trial, rapid eye movement sleep, route of administration, shelf life, sleep, solution, sports medicine, tablet (pharmacy), tetrahydrocannabinol, tetrahydrocannabinolic acid, tetrahydrocannabivarin, transparency and translucency, vaporizer (inhalation device)
Joseph Rosado
Physician and Medical Director at International Medical Consultants and Cannabidiol Life
adalimumab, alzheimer's disease, analgesic, anticoagulant, antipsychotic, arthritis, autoimmune disease, benzodiazepine, bioavailability, bipolar disorder, bleeding, brand, budtender, cancer, cannabidiol, cannabinoid, cannabinol, cannabis, cannabis (drug), cannabis indica, cannabis industry, cannabis sativa, cannabis strain, certificate of analysis, depression (mood), dispensary, dopamine, dose (biochemistry), dravet syndrome, drug overdose, edema, education, effects of cannabis, emergency department, emergency medical technician, endocannabinoid system, epilepsy, fibromyalgia, food and drug administration, free market, good manufacturing practice, gpr55, hair loss, hiv, homeostasis, hydroxychloroquine, hypertension, indication (medicine), insomnia, irritable bowel syndrome, lupus, medical cannabis, medical prescription, medical school, medicine, mental disorder, mental health, methotrexate, morphine, norepinephrine, omega-6 fatty acid, opiate, opioid, oxycodone, oxycodone/paracetamol, pain management, paracetamol, paramedic, parkinson's disease, pediatrics, peripheral neuropathy, pharmaceutical industry, pharmacology, physician, placebo, placebo-controlled study, post-traumatic stress disorder, prescription drug, psilocybin mushroom, psychological trauma, randomized controlled trial, rhabdomyosarcoma, rheumatoid arthritis, schizophrenia, serotonin, spasticities, sports medicine, syndrome, tetrahydrocannabinol, tetrahydrocannabinolic acid, tetrahydrocannabivarin, therapeutic index, tony montana, topical medication, transgenerational trauma, vaporizer (inhalation device), warfarin
Jeff Konin
Clinical Professor at College of Nursing & Health Sciences at Florida International University
arthritis, bioavailability, brand, budtender, cannabidiol, cannabinoid, cannabinoid receptor type 1, cannabinoid receptor type 2, cannabinol, cannabis, cannabis (drug), cannabis edible, cannabis indica, cannabis sativa, carbamazepine, chemistry, consumer protection, cytochrome p450, dietary supplement, dose (biochemistry), dream, drug development, effects of cannabis, emergency department, emulsion, endocannabinoid system, fibromyalgia, food and drug administration, gpr55, health, homeostasis, human, hydroxychloroquine, ibuprofen, medical school, medicine, memory, morphine, omega-3 fatty acid, omega-6 fatty acid, opiate, paracetamol, petroleum, pharmaceutical formulation, pharmaceutical industry, pharmacokinetics, pharmacology, placebo, psilocybin mushroom, randomized controlled trial, rapid eye movement sleep, route of administration, shelf life, sleep, solution, sports medicine, tablet (pharmacy), tetrahydrocannabinol, tetrahydrocannabinolic acid, tetrahydrocannabivarin, transparency and translucency, vaporizer (inhalation device)
Kevin Carrillo
Chief Operating Officer at Cannabinoid Nation
advertising, arthritis, audience measurement, blog, brand, brand awareness, budtender, cannabidiol, cannabinoid, cannabinol, cannabis, cannabis (drug), cannabis edible, chocolate, coca-cola, contract, dietary supplement, digital marketing, effects of cannabis, emergency department, endocannabinoid system, facebook, fibromyalgia, food, food science, game balance, google, google search, gpr55, hashtag, homeostasis, hot chocolate, hydroxychloroquine, instagram, internet, linkedin, liquid, medical school, medicine, minimum viable product, money, morphine, news, newspaper, opiate, pay to play, pepsi, placebo, product sample, psilocybin mushroom, randomized controlled trial, research, search engine optimization, shelf life, small business, social media, social media marketing, sports medicine, tetrahydrocannabinol, tetrahydrocannabinolic acid, tetrahydrocannabivarin, twitter, vaporizer (inhalation device), whole foods market, yeast, youtube
Adam Abodeely
Board Certified Surgeon & CEO-Founder at ReserveMD
adoption, allosteric modulator, alternative medicine, anesthesia, anticoagulant, antihypertensive drug, appetite, audit, background check, bank, benzodiazepine, best practice, bioavailability, bleeding, bloating, blood sugar level, board certification, brand, breathing, budtender, c-reactive protein, cancer, cannabidiol, cannabinoid, cannabinoid receptor type 1, cannabinoid receptor type 2, cannabinol, cannabis, cannabis (drug), cannabis sativa, carbohydrate, central processing unit, charlotte's web (cannabis), chemotherapy, chemotherapy-induced nausea and vomiting, clinical trial, commerce clause, controlled substances act, craft brewery and microbrewery, crohn's disease, dementia, depression (mood), diarrhea, dietary supplement, disease, dose (biochemistry), drug, drug development, drug overdose, due diligence, edema, emergency department, endocannabinoid system, entourage effect, fda food safety modernization act, fda warning letter, fibromyalgia, flavonoid, food, food and drug administration, food safety, foodborne illness, gastrointestinal disease, gastroparesis, general surgery, good manufacturing practice, gut–brain axis, headache, heartburn, hemp, hemp oil, heroin, homeostasis, ibuprofen, ileostomy, immune system, indication (medicine), inflammation, inflammatory bowel disease, inhaler, intestinal permeability, iso 9000, lemon, lobbying, lung volumes, macrophage, medical cannabis, medical prescription, medication, mind, morphine, nanotechnology, nausea, neurology, neuron, neurosurgery, neurotransmitter, nicotine, nsf international, nutraceutical, opiate, opioid, opioid epidemic in the united states, opioid overdose, over-the-counter drug, oxycodone, oxycodone/paracetamol, pain, pain management, pathology, patient, personalized medicine, pharmaceutical industry, pharmacogenomics, pharmacokinetics, pharmacology, pharmacy, physician, placebo, placebo-controlled study, polypharmacy, prescription drug, psychoactive drug, quality management system, reason, regulatory compliance, rhabdomyosarcoma, risk, route of administration, safety, scientific method, sensitivity and specificity, serotonin, serotonin syndrome, signal transduction, spasticities, stress (biology), surgery, synthetic cannabinoids, terminal illness, terpene, tetrahydrocannabinol, tetrahydrocannabinol acid, therapeutic index, therapy, toxicity, ulcerative colitis, understanding, verification and validation, warfarin, water
Daniel Yazbeck
Founder at Yazbeck Investment Group
adoption, bioavailability, breathing, budtender, cannabidiol, cannabinoid, cannabis (drug), dietary supplement, dose (biochemistry), drug, inhaler, lung volumes, medical cannabis, medication, nanotechnology, pain, patient, pharmaceutical industry, risk, route of administration, serotonin, serotonin syndrome, terpene, tetrahydrocannabinol
Charles Piermarini
CEO at Restorative CBD
absorption (pharmacology), adoption, allosteric regulation, anti-inflammatory, anticoagulant, anticonvulsant, antiviral drug, benzodiazepine, bioavailability, breathing, budtender, cancer, cannabidiol, cannabinoid, cannabinoid receptor type 2, cannabinol, cannabis, cannabis (drug), certificate of analysis, clinical trial, coronavirus disease 2019, cytochrome p450, dietary supplement, dose (biochemistry), drug, drug interaction, drug overdose, flax, geriatrics, grapefruit–drug interactions, infection, inhaler, insomnia, ligand (biochemistry), lung volumes, medical cannabis, medication, melatonin, nanotechnology, omega-3 fatty acid, omega-6 fatty acid, opioid, over-the-counter drug, oxycodone/paracetamol, pain, patient, pharmaceutical industry, pharmacology, pharmacy, prothrombin time, pulmonary embolism, risk, route of administration, sense, serotonin, serotonin syndrome, signal transduction, sleep disorder, stroke, terpene, tetrahydrocannabinol, tetrahydrocannabinolic acid, tetrahydrocannabivarin, therapeutic index, warfarin
Lynn Marie Morski
Medical Director at WayofLeaf
adoption, behavior, bioavailability, brand, breathing, budtender, cannabidiol, cannabinoid, cannabinoid receptor type 1, cannabinoid receptor type 2, cannabis, cannabis (drug), commodity, dietary supplement, dose (biochemistry), drug, electronic cigarette, entourage effect, farmer, genetically modified food, hemp, herbicide, inhaler, insomnia, lung volumes, medical cannabis, medication, nanotechnology, nsf international, organic certification, pain, patient, pharmaceutical industry, price, risk, route of administration, serotonin, serotonin syndrome, solution, terpene, tetrahydrocannabinol, tobacco, warren buffett
Tristan Watkins
Chief Science Officer (CSO) at LucidMood
23andme, adolescence, aromatherapy, aromaticity, bicycle, biotechnology, brand, budtender, cannabidiol, cannabinoid, cannabis, cannabis (drug), cannabis indica, cannabis sativa, chromium, concept, creativity, curveball, dietary supplement, disease, dose (biochemistry), drink, electronic cigarette, engineer, entourage effect, epilepsy, food, food and drug administration, genetics, good manufacturing practice, hemp, herbal medicine, inflammation, insomnia, ligand (biochemistry), limonene, market (economics), medical cannabis, medication, medicine, memory, mind, pharmaceutical industry, placebo, questionnaire, race (human categorization), relaxation (psychology), reverse engineering, route of administration, science, sedative, sense, slider (baseball), synergy, terpene, tetrahydrocannabinol, time, traditional chinese medicine, washington (state), zolpidem
1
1-13 of 13